VYCOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (10 4月 2024 @ 04:52):

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision...

Stats
本日の出来高	728.00
平均出来高	4 082.00
時価総額	2.74M
EPS	$0 ( 2024-04-16 )
次の収益日	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.40
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2022-06-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2022-03-31	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2021-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2021-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock

INSIDER POWER
100.00
Last 99 transactions
Buy: 21 534 905 \| Sell: 2 437 499

Vycor Medical, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Vycor Medical, Inc. 財務諸表

Annual	2023
収益:	$1.46M
総利益:	$1.32M (90.08 %)
EPS:	$-0.00210

FY	2023
収益:	$1.46M
総利益:	$1.32M (90.08 %)
EPS:	$-0.00210

FY	2022
収益:	$1.22M
総利益:	$1.08M (88.50 %)
EPS:	$-0.0128

FY	2021
収益:	$1.39M
総利益:	$1.26M (90.33 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

Vycor Medical, Inc.

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.